Access to Breast Cancer Diagnosis Act of 2025
United States119th CongressHR-3037House of Representatives
Updated: Apr 28, 2025
Summary
This bill aims to eliminate financial barriers to critical breast cancer detection by prohibiting group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. It amends the Public Health Service Act to ensure that medically necessary services, including diagnostic mammography, MRI, and ultrasound, are covered without deductibles, copayments, or coinsurance. The legislation defines diagnostic breast examinations as those evaluating abnormalities and supplemental breast examinations as screenings for individuals with increased risk factors. While prohibiting cost-sharing, the bill allows plans to require prior authorization and applies to "grandfathered" health plans, without superseding stronger state laws. Additionally, it amends the Internal Revenue Code to permit high-deductible health plans (HDHPs) to cover these examinations without a deductible, preserving Health Savings Account (HSA) eligibility. These provisions will take effect for plan years beginning on or after January 1, 2026, enhancing access to essential breast cancer care.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-1500: Access to Breast Cancer Diagnosis Act of 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
Introduced in House
All available records shown.